STOCK TITAN

Zhongchao Inc - ZCMD STOCK NEWS

Welcome to our dedicated news page for Zhongchao (Ticker: ZCMD), a resource for investors and traders seeking the latest updates and insights on Zhongchao.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zhongchao's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zhongchao's position in the market.

Rhea-AI Summary
Zhongchao Inc. (ZCMD) announces successful medication assistance services for over 7,000 low-income Systemic Lupus Erythematosus patients, reducing financial burdens. Zhongxin provided Titazepam and Belimumab for free through patient aid projects, distributing 130,000 units of medication.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.16%
Tags
none
-
Rhea-AI Summary
Zhongchao Inc. (NASDAQ: ZCMD) announced the approval of a 1-for-10 share consolidation to regain compliance with Nasdaq rules, effective February 29, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.83%
Tags
none
-
Rhea-AI Summary
Zhongchao Inc. (NASDAQ: ZCMD) has renewed its service agreement with Beijing Public Health Foundation to extend its partnership for a patient aid project providing free Doxorubicin Hydrochloride Liposome Injections to low-income cancer patients. The Project has been in operation for three years, serving over 6,000 patients and donating more than 22,000 doses of medication.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-31.06%
Tags
none
Rhea-AI Summary
Zhongchao Inc. launches a WeChat mini program to provide comprehensive health management and follow-up guidance for breast cancer patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
none
-
Rhea-AI Summary
Zhongchao introduces PRO-based symptom management model for lung cancer patients, aiming to enhance their life quality and recovery process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Zhongchao Inc. achieves milestone of serving over 10,000 breast cancer patients in China with disease management services, addressing rising demand and financial burdens.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.72%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.68%
Tags
none
Rhea-AI Summary
Zhongchao Inc. integrates its drug Naiditawei® into the procurement scope of medical treatment drugs across ten provinces in China, which is expected to alleviate supply pressure and contribute positively to the healthcare sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Zhongchao Inc

Nasdaq:ZCMD

ZCMD Rankings

ZCMD Stock Data

3.16M
1.30M
13.67%
0.2%
0.45%
Elementary and Secondary Schools
Educational Services
Link
China
Shanghai